Experimental results showed that TRAIP downregulates the expression of IGFBP3 by promoting the ubiquitination and degradation of KANK1, thereby activating the AKT pathway and promoting the proliferation and invasion of osteosarcoma cells [132]. The gene discussed is AKT1; the disease is osteosarcoma.